• Ceftolozane/Tazobactam: Evidence and Clinical Use

  2026-09-18

  The reference review presents ceftolozane/tazobactam as an antipseudomonal cephalosporin/β-lactamase inhibitor combination designed to address resistant gram-negative infections. Its main contribution is an integrated interpretation of antibacterial mechanism, resistance, pharmacokinetics, pharmacodynamics, clinical evidence, dosing, and safety rather than a single new experimental result.

• CLCC1 and Herpesvirus Nuclear Egress Fusion

  2026-09-18

  A bioRxiv study identifies the host protein CLCC1 as an essential factor in the membrane-fusion step of HSV-1 nuclear egress, resolving a major gap in the herpesvirus replication pathway. The findings connect viral capsid release with nuclear pore complex insertion and provide a mechanistic framework for studying host-directed antiviral strategies.

• IL-12 and the Next Wave of MRSA Translation

  2026-09-17

  YZ462 highlights how direct membrane disruption can address MRSA persistence, while Recombinant Human IL-12 offers a research framework for studying host immune context. This article separates evidence from hypothesis and outlines a translational workflow for evaluating host-directed strategies alongside antibacterial mechanisms.

• Eltanexor: Reframing Nuclear Export in Cancer

  2026-09-17

  Eltanexor (KPT-8602) offers translational researchers a way to study XPO1 biology across hematologic malignancies and colorectal cancer. This thought-leadership perspective connects nuclear retention, Wnt/β-catenin signaling, experimental design, and strategic model selection while distinguishing preclinical promise from clinical evidence.

• Recombinant Human IL-15 for Neuroimmune Assays

  2026-09-16

  Recombinant Human IL-15 provides a controlled immune-cell stimulus for T-cell and NK-cell assays that can be paired with behavioral and circuit-level studies of early life adversity. This guide translates the product specifications into practical workflows while keeping the IL-15–oxytocin relationship appropriately hypothesis-generating.

• NBC19 for NLRP3 Inflammasome Research

  2026-09-16

  NBC19 is a nanomolar NLRP3 inflammasome inhibitor for dissecting IL-1β release in differentiated THP-1 assays and exploratory myeloid-cell models. This guide connects reproducible compound handling with practical workflows inspired by recent research on circulating cancer-associated macrophage-like cells.

• NBC19 for Reproducible NLRP3 Assays

  2026-09-15

  A scenario-based guide to using NBC19 (SKU BA6129) as an NLRP3 inflammasome inhibitor in cytokine, viability, and cytotoxicity workflows. It connects product-backed potency and handling data with practical assay design, interpretation, and vendor-selection decisions.

• Hexose Diphosphate: Designing Better Metabolic Assays

  2026-09-15

  Hexose diphosphate is a versatile hexose phosphate for connecting glycolytic flux with energy homeostasis research. This article explains how to use it responsibly in metabolic and inflammation workflows while distinguishing pathway effects from direct signaling mechanisms.

• TRIM21–ERK1/2 Signaling in Pituitary Adenomas

  2026-09-14

  The reference study identifies TRIM21 as a context-dependent regulator of ERK1/2 signaling, pituitary adenoma proliferation, and resistance to dopamine-directed therapy. By combining CRISPR screening, biochemical validation, animal studies, and NanoBiT drug screening, it nominates TRIM21 suppression—and compounds such as Quisinostat—as a mechanistically testable strategy.

• Network Medicine Identifies Apigenin for Alzheimer’s

  2026-09-14

  A 2025 study used network proximity analysis to screen flavonoids against Alzheimer’s disease targets and identified Apigenin as the leading candidate among four experimentally tested compounds. Cellular validation linked its neuroprotective activity to mitochondrial preservation, reduced apoptosis, AKT/NF-κB pathway suppression, and regulation of microglial inflammatory states.

• Curcumin, NLRP3, and HUVEC Pyroptosis

  2026-09-13

  A study in Molecular Medicine Reports shows that curcumin protects human umbilical vein endothelial cells from H2O2-induced injury by suppressing NLRP3-associated pyroptosis. Its use of caspase-1 and NLRP3 inhibitors strengthens the mechanistic interpretation and provides a practical framework for studying endothelial inflammation.

• Ziprasidone HCl: Mechanisms and Research Benchmarks

  2026-09-12

  Ziprasidone HCl combines established serotonin–dopamine receptor pharmacology with reported GOT1 inhibition in pancreatic cancer models. This article separates clinical neuropsychiatric use from preclinical oncology evidence and organizes assay, formulation, and dosing parameters for reproducible research.

• Alternariol (AOH): Mechanisms & Research Workflow

  2026-09-11

  Alternariol, also called AOH, is an emerging Alternaria mycotoxin with documented effects on steroid secretion, cell viability, apoptosis, cytoskeletal proteins, and hepatic stellate-cell activation. This article separates established product and literature findings from practical assay recommendations for mycotoxin research, cytochrome P450 enzyme assays, and apoptosis mechanism research.

• Lactate–HMGB1 Signaling in Polymicrobial Sepsis

  2026-09-11

  The reference study identifies lactate as an active regulator of macrophage HMGB1 modification and exosomal release, rather than merely a clinical marker of sepsis severity. Its integrated cell, genetic, exosome, endothelial, and mouse experiments connect lactate transport and GPR81-associated signaling with vascular permeability and survival, offering a mechanistic framework for inflammation research.

• Early Life Adversity, Oxytocin, and Innate Fear

  2026-09-10

  This 2026 Communications Biology study links early life adversity to impaired looming-evoked defensive behavior in mice and identifies deficient oxytocin signaling in the superior colliculus as a mechanistic pathway. Its combination of developmental stress modeling, circuit analysis, receptor manipulation, and intranasal oxytocin rescue provides a framework for studying how early experience alters innate threat processing.

8495 records 1/567 page Next 12345 下5页 Last page